EUVIMEDEUVIMED entdecken
Fallbericht

Topical Diclofenac to Manage Opioid-Refractory Pain in a Rare Pancreatic Fibrosarcoma

Syed H Ali iD, Tyler Jorgensen, Rohit K Prasad, Gregory Wallingford

Journal of Palliative Medicine · 2024

DOI: 10.1089/jpm.2023.0339 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Palliative Medicine, 2024. Verfasst von Syed H Ali und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and University of Texas at Austin Dell Medical School, Austin, Texas, USA. Hauptthemen laut MEDLINE: Intractable Pain, Pancreatic Neoplasms, Celiac Plexus. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer is often diagnosed at an advanced stage and is frequently associated with severe pain. Traditional pain management in this condition may be improved with the use of topical diclofenac. A 39-year-old man with advanced pancreatic fibrosarcoma metastatic to the thoracic spine presented to the hospital with severe abdominal pain refractory to escalating doses of opioids. A celiac plexus block produced significant, yet inadequate, pain reduction. Satisfactory pain control and opioid de-escalation were ultimately achieved with the application of topical diclofenac gel to an area of bony metastasis. This case illustrates the potential for pain control using topical diclofenac in patients with pancreatic soft tissue tumors and vertebral metastases. Topical diclofenac may exert antitumoral effects and targeted application may improve absorption, leading to improved pain control. The use of topical diclofenac for pain management in metastatic pancreatic cancer presents an interesting tool that should be considered in similar cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intractable PainPancreatic NeoplasmsCeliac PlexusMaleHumansAdultDiclofenacAnalgesics, OpioidPain ManagementAnti-Inflammatory Agents, Non-Steroidal

Stichwörter der Autor:innen

celiac plexus blockdiclofenacopioid-refractory painpancreatic fibrosarcoma

Substanzen

DiclofenacAnalgesics, OpioidAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Medicine and University of Texas at Austin Dell Medical School, Austin, Texas, USA.
  • Department of Hospice and Palliative Medicine, University of Texas at Austin Dell Medical School, Austin, Texas, USA.
  • University of Texas at Austin Dell Medical School, Austin, Texas, USA.

ORCID-Profile: Syed H Ali

Zitieren

APA

Ali, S. H., Jorgensen, T., Prasad, R. K., & Wallingford, G. (2024). Topical Diclofenac to Manage Opioid-Refractory Pain in a Rare Pancreatic Fibrosarcoma. Journal of Palliative Medicine. https://doi.org/10.1089/jpm.2023.0339

Vancouver

Ali SH, Jorgensen T, Prasad RK, Wallingford G. Topical Diclofenac to Manage Opioid-Refractory Pain in a Rare Pancreatic Fibrosarcoma. Journal of Palliative Medicine. 2024. doi:10.1089/jpm.2023.0339

BibTeX
@article{Ali2024,
  author = {Ali, Syed H and Jorgensen, Tyler and Prasad, Rohit K and Wallingford, Gregory},
  title = {Topical Diclofenac to Manage Opioid-Refractory Pain in a Rare Pancreatic Fibrosarcoma},
  journal = {Journal of Palliative Medicine},
  year = {2024},
  doi = {10.1089/jpm.2023.0339}
}
Kostenlos starten →